CCM
CAAS Capital Management Portfolio holdings
AUM
$211M
This Quarter Return
+0.27%
1 Year Return
+0.26%
3 Year Return
-2.04%
5 Year Return
+39.32%
10 Year Return
–
AUM
$520M
AUM Growth
+$520M
(-32%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-47.7%
Top 10 Holdings %
Top 10 Hldgs %
37.93%
Holding
754
New
180
Increased
35
Reduced
49
Closed
228
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$51.1M |
| 2 |
Cencora
COR
|
$25.3M |
| 3 |
Novavax
NVAX
|
$10.3M |
| 4 |
Laureate Education
LAUR
|
$9.84M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$8.76M |
Top Sells
| 1 |
Agree Realty
ADC
|
$43.9M |
| 2 |
Constellation Energy
CEG
|
$40.6M |
| 3 |
Philip Morris
PM
|
$38.3M |
| 4 |
Match Group
MTCH
|
$13M |
| 5 |
Global E Online
GLBE
|
$12.4M |
Sector Composition
| 1 | Financials | 28.13% |
| 2 | Technology | 18.32% |
| 3 | Healthcare | 17.41% |
| 4 | Industrials | 7.35% |
| 5 | Consumer Discretionary | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Ubiquiti
UI
$32B
| $547K | 0.03% |
+2,000
| New | +$547K |
|
127
ASML
ASML
$292B
| $546K | 0.03% |
1,000
-22,200
| -96% | -$12.1M |
|
128
Thermo Fisher Scientific
TMO
$186B
| $546K | 0.03% |
+991
| New | +$546K |
|
129
Home Depot
HD
$405B
| $543K | 0.03% |
1,720
-15,440
| -90% | -$4.88M |
|
130
Broadridge
BR
$29.9B
| $537K | 0.03% |
+4,000
| New | +$537K |
|
131
Salesforce
CRM
$245B
| $530K | 0.03% |
4,000
-3,701
| -48% | -$491K |
|
132
CRISPR Therapeutics
CRSP
$4.71B
| $528K | 0.03% |
+13,000
| New | +$528K |
|
133
Veru
VERU
$47.6M
| $528K | 0.03% |
+100,000
| New | +$528K |
|
|
ZING
134
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
| $527K | 0.03% |
52,345
+195
| +0.4% | +$1.96K |
|
135
McDonald's
MCD
$224B
| $527K | 0.03% |
+2,000
| New | +$527K |
|
136
BioAtla
BCAB
$26.7M
| $527K | 0.03% |
+63,838
| New | +$527K |
|
137
CrowdStrike
CRWD
$106B
| $526K | 0.03% |
+5,000
| New | +$526K |
|
|
BPMC
138
DELISTED
Blueprint Medicines
BPMC
| $526K | 0.03% |
+12,000
| New | +$526K |
|
139
Expedia Group
EXPE
$26.6B
| $526K | 0.03% |
6,000
-1,923
| -24% | -$168K |
|
140
Entegris
ENTG
$12.7B
| $525K | 0.03% |
+8,000
| New | +$525K |
|
141
Glaukos
GKOS
$5.5B
| $524K | 0.03% |
+12,000
| New | +$524K |
|
142
ChargePoint
CHPT
$263M
| $524K | 0.03% |
+55,000
| New | +$524K |
|
|
CCVI
143
DELISTED
Churchill Capital Corp VI
CCVI
| $524K | 0.03% |
52,400
| – | – |
|
144
Intellia Therapeutics
NTLA
$1.22B
| $523K | 0.03% |
+15,000
| New | +$523K |
|
145
Edwards Lifesciences
EW
$47.8B
| $522K | 0.03% |
+7,000
| New | +$522K |
|
146
Lumentum
LITE
$9.28B
| $522K | 0.03% |
+10,000
| New | +$522K |
|
|
QDRO
147
DELISTED
Quadro Acquisition One Corp. Class A Ordinary Shares
QDRO
| $521K | 0.03% |
51,600
| – | – |
|
148
Gildan
GIL
$8.14B
| $521K | 0.03% |
+19,000
| New | +$521K |
|
149
Yelp
YELP
$1.99B
| $519K | 0.03% |
+19,000
| New | +$519K |
|
150
Marvell Technology
MRVL
$54.2B
| $519K | 0.03% |
14,000
+10,903
| +352% | +$404K |
|